The Scientist

» ebola and disease/medicine

Most Recent

image: FDA Gives Nod to Melanoma Drug

FDA Gives Nod to Melanoma Drug

By | September 8, 2014

The US Food and Drug Administration last week approved the first of a new type of immunotherapy that aims to pit a patient’s own immune system against her cancer.

2 Comments

image: UN Calls for $600M in Aid to Stop Ebola

UN Calls for $600M in Aid to Stop Ebola

By | September 4, 2014

The United Nations and medical organizations request additional international action on Ebola as the pace of the ongoing epidemic accelerates.

0 Comments

image: Funds To Speed Ebola Drug Development

Funds To Speed Ebola Drug Development

By | September 4, 2014

A $42 million US government contract awarded to an experimental Ebola medicine maker aims to accelerate the process of meeting demand for the therapeutic.

0 Comments

The ALS Association has raised more than $100 million in donations through a charity campaign that went viral. How should that money be spent?

1 Comment

image: NIH To Speed Ebola Vax Trials

NIH To Speed Ebola Vax Trials

By | September 2, 2014

The ongoing Ebola outbreak has prompted the National Institutes of Health to accelerate human trials of multiple Ebola vaccines, starting this week.

0 Comments

image: Experimental Ebola Drug Shows Promise

Experimental Ebola Drug Shows Promise

By | September 2, 2014

ZMapp effectively rescued macaques from Ebola in a small trial, but it could be several months before supplies of the drug meet the growing human demand for it.

1 Comment

image: Crossing Boundaries

Crossing Boundaries

By | September 1, 2014

A groundbreaker in the study of Listeria monocytogenes, Pascale Cossart continues to build her research tool kit to understand how to fight such intracellular human pathogens.

0 Comments

image: Head Scratchers

Head Scratchers

By | September 1, 2014

Many natural phenomena elude our understanding.

5 Comments

image: Speaking of Science

Speaking of Science

By | September 1, 2014

September 2014's selection of notable quotes

0 Comments

image: The Second Coming of RNAi

The Second Coming of RNAi

By | September 1, 2014

Now showing clinical progress against liver diseases, the gene-silencing technique begins to fulfill some of its promises.

1 Comment

Popular Now

  1. Man Receives First In Vivo Gene-Editing Therapy
  2. Long-term Study Finds That the Pesticide Glyphosate Does Not Cause Cancer
  3. Researchers Build a Cancer Immunotherapy Without Immune Cells
  4. Research Links Gut Health to Neurodegeneration
    The Nutshell Research Links Gut Health to Neurodegeneration

    Rodent studies presented at the Society for Neuroscience meeting this week tie pathologies in the gastrointestinal tract or microbiome composition with Parkinson’s and Alzheimer’s diseases.

RayBiotech